Markus Goebel, MD, PhD, MBA

Managing Director, Novartis Venture Funds

Markus Goebel started his career in the healthcare industry in 1990. An MD by training and certified, amongst others, in hematology/oncology he worked for Farmitalia Germany and later held several global positions in R&D, Marketing and Strategy at Roche headquarters to include a worldwide alliance with Amgen. He joined Novartis in 2000 and first worked as Global Head Nervous System BD&L Pharma and later as Global Head Pharma Corporate M&A. In 2004, he joined the Novartis Venture Fund (NVF) as a managing director in the US, moving back to Europe in 2009. He was appointed to be NVF Company Manager US in 2017. Previously, he received an MD and a PhD from the Ludwig Maximilian’s University in Munich and an MBA from Henley Management College. Dr. Goebel serves on the boards of several Novartis Venture Fund portfolio companies.